January 10th 2024
The oral TRT study plans to enroll 20 male patients aged 18 to 49 years who meet the American Urological Association’s criteria for hypogonadism and who have not previously used TRT.
September 28th 2023
Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings
View More
New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
March 8-9, 2024
Register Now!
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies
View More
Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer
View More
Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Testicular tissue cryopreservation offers hope to prepubescent males at risk for infertility
December 21st 2022A team of Cleveland Clinic urologists and pediatric oncologists has developed a streamlined testicular tissue collection and storage process. They have enrolled and cryopreserved testicular tissue for nearly a dozen young patients so far.
Male sexual health and reproductive medicine: All that glitters is not gold
September 19th 2022"With the average cost of treatment ranging from $2600 to $3900 per cycle, clinics offering radial wave therapy have an obvious financial incentive to continue marketing despite the lack of evidence of its effectiveness," write Navid Leelani, DO, and Scott D. Lundy, MD, PhD.
Patient counseling in regard to e-cigarettes and erectile dysfunction
March 19th 2022In this interview, Omar El Shahawy, MD, MPH, PhD, discusses patient counseling in regard to e-cigarette use or vaping by using data from a recent study on evaluating the association of e-cigarette use and erectile dysfunction.
Dr. Burnett on Viagra: “This transformed the field in a significant way”
March 2nd 2022In this installment of the Urology Times' 50th Anniversary Innovation Celebration, Arthur L. Burnett, MD, MBA, FACS, discusses how sildenafil citrate (Viagra) has been an integral part of erectile dysfunction management for decades.
Penile curvature improvement in Peyronie's disease assessed in post hoc analysis of IMPRESS trials
October 29th 2021“The goal of this study was to look at that original phase 3 trial data [from 2013] and see if we could identify how much change in curvature patients were achieving with each of those 2 injections,” says Matthew J. Ziegelmann, MD.
Study investigates potential link between type 1 diabetes and male infertility
August 27th 2021"Interestingly, we found that the prevalence of male infertility in men with type 1 diabetes was 1.5%, comprising 33 out of more than 2000 men diagnosed with type 1 diabetes who reported male infertility," says Omer A. Raheem, MD, MSc, in this interview.
Dr. Andino assesses how telemedicine can be used efficiently in future urological follow-up visits
August 22nd 2021“Being able to have a follow-up visit that is convenient, that saves time, that saves money, but that can allow you to put everything together for the patient…is still a very valuable tool,” says Juan José Andino, MD.
Dr. Andino discusses telehealth for male infertility appointments
August 19th 2021"None of our patients had unexpected appointments that had to be made after their video encounters…supporting this idea that at least in urology, it seems that telehealth is a substitute for inpatient care when appropriately selected by the physician,” says Juan José Andino, MD.
Dr. Ranjith Ramasamy discusses research evaluating COVID-19 and erectile dysfunction
May 19th 2021“I think doctors should be aware that if men do complain of erectile dysfunction after [having] COVID-19 that it could be because of underlying endothelial dysfunction and underlying vasculature issues,” Ramasamy says.